The idiopathic interstitial pneumonias are part of the wide spectrum of diffuse parenchymal lung diseases (Fig. 19.1).1 While recognition of diffuse interstitial pulmonary fibrosis can be traced back to studies by Hamman and Rich2 in the 1930s and 1940s, they were first classified as a set of histopathologic patterns in the 1960s by Liebow and Carrington3 into usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), bronchiolitis obliterans with interstitial pneumonia (BIP), giant cell interstitial pneumonia (GIP) and lymphoid interstitial pneumonia (LIP). At about the same time, Scadding4 in the United Kingdom proposed the term fibrosing alveolitis, suggesting (incorrectly) that DIP and UIP were early and late phases of a single disorder.5 There has subsequently been much discussion and controversy over what patterns should be included in such a classification system, in terms of both histology and what these patterns represent regarding clinical disease. As a result, some patterns have now been categorized according to their recognized causes; for example, GIP has been reclassified as a pneumoconiosis, the cause being exposure to cobalt during the production of hard metals or during diamond polishing (see Chapter 26).6,7


Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Interstitial Pneumonia Respir Crit Usual Interstitial Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Turner-Warwick M. Interstitial lung disease. Sem Respir Med 1984;6:1–102.Google Scholar
  2. 2.
    Hamman L, Rich A. Acute diffuse interstitial fibrosis of the lung. Bull Johns Hopkins Hosp 1944;74:177.Google Scholar
  3. 3.
    Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, Lemay E, eds. Frontiers in pulmonary radiology. New York: Grune and Stratton, 1969:102–141.Google Scholar
  4. 4.
    Scadding JG. Fibrosing alveolitis. Br Med J 1964;2:686.PubMedGoogle Scholar
  5. 5.
    Scadding JG, Hinson KFW. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967;22:291–304.PubMedGoogle Scholar
  6. 6.
    Anttila S, Sutinen S, Paananen M et al. Hard metal lung disease: a clinical, histological, ultrastructural and X-ray microanalytical study. Eur J Respir Dis 1986;69;83–94.PubMedGoogle Scholar
  7. 7.
    Demedts M, Gheysens B, Nagels J, et al. Cobalt lung in diamond polishers. Am Rev Respir Dis 1984;130:130–135.PubMedGoogle Scholar
  8. 8.
    Myers JL, Veal CF Jr, Shin MS, Katzenstein AL. Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 1987;135;880–884.PubMedGoogle Scholar
  9. 9.
    Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64:1373–1380.PubMedGoogle Scholar
  10. 10.
    Katzenstein AA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136–147.PubMedGoogle Scholar
  11. 11.
    Katzenstein A-L, Myers JL, Mazur MT. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986;10(4):256–267.PubMedGoogle Scholar
  12. 12.
    Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301–1315.PubMedGoogle Scholar
  13. 13.
    American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus Statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646–664.Google Scholar
  14. 14.
    Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213–2217.PubMedGoogle Scholar
  15. 15.
    Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathological subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199–203.PubMedGoogle Scholar
  16. 16.
    Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899–905.PubMedGoogle Scholar
  17. 17.
    Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010–1019.PubMedGoogle Scholar
  18. 18.
    Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns—survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19–33.PubMedGoogle Scholar
  19. 19.
    Flaherty KR, Travis WD, Colby TV, et al. Histopathologic Variability in Usual and Nonspecific Interstitial Pneumonias. Am J Respir Crit Care Med 2001;164:1722–1727.PubMedGoogle Scholar
  20. 20.
    Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002;19:275–283.PubMedGoogle Scholar
  21. 21.
    Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999;211:555–560.PubMedGoogle Scholar
  22. 22.
    Tung KT, Wells AU, Rubens MB, Kirk JM, du BR, Hansell DM. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993;48:334–338.PubMedGoogle Scholar
  23. 23.
    Hansell DM, Wells AU. CT evaluation of fibrosing alveolitis—applications and insights. J Thoracic Imag 1996;11:231–249.Google Scholar
  24. 24.
    American Thoracic Society/ European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277–304.Google Scholar
  25. 25.
    Johnston ID, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax 1997;52:38–44.PubMedGoogle Scholar
  26. 26.
    Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193–196.PubMedGoogle Scholar
  27. 27.
    Myers JL. NSIP, UIP, and the ABCs of idiopathic interstitial pneumonias. Eur Respir J 1998;12:1003–1004.PubMedGoogle Scholar
  28. 28.
    Primack SL, Hartman TE, Hansell DM, Muller NL. Endstage lung disease: CT findings in 61 patients. Radiology 1993;189:681–686.PubMedGoogle Scholar
  29. 29.
    Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801–809.PubMedGoogle Scholar
  30. 30.
    Katzenstein AL, Myers JL, Prophet WD, Corley LS, Shin MS. Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986;10:373–381.PubMedGoogle Scholar
  31. 31.
    Katzenstein A-LA, Askin FB. Idiopathic interstitial pneumonia. In: Katzenstein A-LA, Askin FB, eds. Surgical pathology of non-neoplastic lung disease. Philadelphia: WB Saunders, 1997:48–80.Google Scholar
  32. 32.
    King TE Jr, Schwarz MI, Brown K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001;164:1025–1032.PubMedGoogle Scholar
  33. 33.
    Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The frequency of fibroblastic foci in usual interstitial pneumonia and their relationship to disease progression. Am J Respir Crit Care Med 2002;166:173–177.PubMedGoogle Scholar
  34. 34.
    Britton J, Hubbard R. Recent advances in the aetiology of cryptogenic fibrosing alveolitis. Histopathology 2000;37:387–392.PubMedGoogle Scholar
  35. 35.
    Yousem SA. Eosinophilic pneumonia-like areas in idiopathic usual interstitial pneumonia. Modern Pathol 2000;13:1280–1284.Google Scholar
  36. 36.
    Stack BH, Choo-Kang YF, Heard BE. The prognosis of cryptogenic fibrosing alveolitis. Thorax 1972;27:535–542.PubMedGoogle Scholar
  37. 37.
    Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980;35:171–180.PubMedGoogle Scholar
  38. 38.
    Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 1980;35:593–599.PubMedGoogle Scholar
  39. 39.
    Tukiainen P, Taskinen E, Holsti P, Korhola O, Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983;38:349–355.PubMedGoogle Scholar
  40. 40.
    Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 1998;113:396–400.PubMedGoogle Scholar
  41. 41.
    Johnston IDA, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997;52:38–44.PubMedGoogle Scholar
  42. 42.
    King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171–1181.PubMedGoogle Scholar
  43. 43.
    Marshall RP, Puddicombe A, Cookson WOC, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000;55:143–146.PubMedGoogle Scholar
  44. 44.
    Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987;135:26–34.PubMedGoogle Scholar
  45. 45.
    Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999;14:245–248.PubMedGoogle Scholar
  46. 46.
    Haslam PL, Turton CW, Lukoszek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980;35:328–339.PubMedGoogle Scholar
  47. 47.
    Veeraraghavan S, Latsi PI, Wells AU, et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 2003;22:239–244.PubMedGoogle Scholar
  48. 48.
    Wells AU, Hansell DM, Haslam PL, et al. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 1998;157:1474–1482.PubMedGoogle Scholar
  49. 49.
    Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264–1269.PubMedGoogle Scholar
  50. 50.
    Nathan SD, Barnett SD, Moran B, et al. Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis. Respiration 2004;71:77–82.PubMedGoogle Scholar
  51. 51.
    Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125–133.PubMedGoogle Scholar
  52. 52.
    Meyer A, Buhl R, Kampf S, Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 1995;152:1055–1060.PubMedGoogle Scholar
  53. 53.
    MacNee W, Rahman I. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 1995;50(suppl 1):S53–S58.PubMedGoogle Scholar
  54. 54.
    Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP, III. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 2004;64:405–430.PubMedGoogle Scholar
  55. 55.
    Thannickal VJ, Toews GB, White ES, Lynch JP III, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004;55:395–417.PubMedGoogle Scholar
  56. 56.
    Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980;35:496–499.PubMedGoogle Scholar
  57. 57.
    Kumar P, Goldstraw P, Yamada K, et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003;125:1321–1327.PubMedGoogle Scholar
  58. 58.
    Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003;167:962–969.PubMedGoogle Scholar
  59. 59.
    Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:510–511.Google Scholar
  60. 60.
    Wangoo A, Shaw RJ, Diss TC, Farrell PJ, duBois RM, Nicholson AG. Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. Thorax 1997;52:888–891.PubMedGoogle Scholar
  61. 61.
    Tsukamoto K, Hayakawa H, Sato A, Chida K, Nakamura H, Miura K. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 2000;55:958–961.PubMedGoogle Scholar
  62. 62.
    Stewart JP, Egan JJ, Ross AJ et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999;159:1336–1341.PubMedGoogle Scholar
  63. 63.
    Meliconi R, Andreone P, Fasano L et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996;51:315–317.PubMedGoogle Scholar
  64. 64.
    Hubbard R. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J Suppl 2001;32:119s–121s.PubMedGoogle Scholar
  65. 65.
    Tobin RW, Pope CE, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1804–1808.PubMedGoogle Scholar
  66. 66.
    Hubbard R, Venn A, Smith C, Cooper M, Johnston I, Britton J. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: A case-control study. Am J Respir Crit Care Med 1998;157:743–747.PubMedGoogle Scholar
  67. 67.
    Hubbard R, Venn A, Britton J. Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: a case-control study. Eur Respir J 2000;16:409–413.PubMedGoogle Scholar
  68. 68.
    Wallace WAH, Howie SEM. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease. J Pathol 1999;187:475–480.PubMedGoogle Scholar
  69. 69.
    Whyte M, Hubbard R, Meliconi R, et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000;162:755–758.PubMedGoogle Scholar
  70. 70.
    Pantelidis P, Fanning GC, Wells AU, Welsh KI, du Bois RM. Analysis of tumor necrosis factor-alpha, lymphotoxinalpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;163:1432–1436.PubMedGoogle Scholar
  71. 71.
    Thomas AQ, Lane K, Phillips J III, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322–1328.PubMedGoogle Scholar
  72. 72.
    Kradin RL, Divertie MB, Colvin RB, et al. Usual interstitial pneumonitis is a T-cell alveolitis. Clin Immunol Immunopathol 1986;40:224–235.PubMedGoogle Scholar
  73. 73.
    Wells AU, Lorimer S, Majumdar S, et al. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 1995;8:266–271.PubMedGoogle Scholar
  74. 74.
    Wallace WA, Schofield JA, Lamb D, Howie SE. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994;49:1139–1145.PubMedGoogle Scholar
  75. 75.
    Jakubzick C, Choi ES, Carpenter KJ, et al. Human pulmonary fibroblasts exhibit altered interleukin-4 and interleu-kin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol 2004;164:1989–2001.PubMedGoogle Scholar
  76. 76.
    Keane MP, Arenberg DA, Lynch JP III, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437–1443.PubMedGoogle Scholar
  77. 77.
    Lappi-Blanco E, Soini Y, Kinnula V, Paakko P. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J Pathol 2002;196:220–227.PubMedGoogle Scholar
  78. 78.
    Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 2002;166:382–385.PubMedGoogle Scholar
  79. 79.
    Lappi-Blanco E, Kaarteenaho-Wiik R, Soini Y, Risteli J, Paakko P. Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized. Hum Pathol 1999;30:1192–1196.PubMedGoogle Scholar
  80. 80.
    Ebina M, Shimizukawa M, Shibata N, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004;169:1203–1208.PubMedGoogle Scholar
  81. 81.
    Renzoni EA. Neovascularization in idiopathic pulmonary fibrosis: too much or too little? Am J Respir Crit Care Med 2004;169:1179–1180.PubMedGoogle Scholar
  82. 82.
    Nicholson AG, Gibbs AR, Addis BJ, et al. Interobserver variation in diffuse parenchymal lung disease. Thorax 2004;59:500–505.PubMedGoogle Scholar
  83. 83.
    Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004;125:522–526.PubMedGoogle Scholar
  84. 84.
    Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58:143–148.PubMedGoogle Scholar
  85. 85.
    Ognibene FP, Masur H, Rogers P, et al. Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1988;109:874–879.PubMedGoogle Scholar
  86. 86.
    MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001;221:600–605.PubMedGoogle Scholar
  87. 87.
    Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia: Variable appearance at high-resolution chest CT. Radiology 2000;217:701–705.PubMedGoogle Scholar
  88. 88.
    Akira M, Inoue G, Yamamoto S, Sakatani M. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000;55:854–859.PubMedGoogle Scholar
  89. 89.
    Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158:1286–1293.PubMedGoogle Scholar
  90. 90.
    Nicholson AG, Wells AU. Nonspecific interstitial pneumonia—nobody said it’s perfect. Am J Respir Crit Care Med 2001;164:1553–1554.PubMedGoogle Scholar
  91. 91.
    Hansell DM, Nicholson AG. Smoking related diffuse parenchymal lung disease: HRCT-pathologic correlation. Sem Respir Crit Care Med 2003;24:377–392.Google Scholar
  92. 92.
    Bouros D, Nicholson AG, Colby TV, et al. Histopathological subsets of fibrosing alveolitis in patients with scleroderma and their relationship to natural history and treated course. Am J Respir Crit Care Med 2002;165:1581–1586.PubMedGoogle Scholar
  93. 93.
    Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182–1185.PubMedGoogle Scholar
  94. 94.
    Tansey D, Wells AU, Colby TV, et al. Variations in histologic patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585–596.PubMedGoogle Scholar
  95. 95.
    Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic and pathologic study. Am J Respir Crit Care Med 2005;171:632–638.PubMedGoogle Scholar
  96. 96.
    Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974;291:755–758.PubMedGoogle Scholar
  97. 97.
    Moon J, du Bois RM, Colby TV, Hansell DM, Nicholson AG. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999;54:1009–1014.PubMedGoogle Scholar
  98. 98.
    Fraig M, Shreesha U, Savici D, Katzenstein AL. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002;26:647–653.PubMedGoogle Scholar
  99. 99.
    King TE. Respiratory bronchiolitis-associated interstitial lung disease. Clin Chest Med. 1993;14:693–698.PubMedGoogle Scholar
  100. 100.
    Park JS, Brown KK, Tuder RM, Hale VA, King Jr TE, Lynch DA. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 2002;26:13–20.PubMedGoogle Scholar
  101. 101.
    Heyneman LE, Ward S, Lynch DA, RemyJardin M, Johkoh T, Muller NL. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: Different entities or part of the spectrum of the same disease process? Am J Roentgenol 1999;173:1617–1622.Google Scholar
  102. 102.
    Agius RM, Rutman A, Knight RK, Cole PJ. Human pulmonary alveolar macrophages with smokers’ inclusions: their relation to the cessation of cigarette smoking. Br J Exp Pathol 1986;67:407–413.PubMedGoogle Scholar
  103. 103.
    Remy-Jardin M, Edme JL, Boulenguez C, Remy J, Mastora I, Sobaszek A. Longitudinal follow-up study of smoker’s lung with thin-section CT in correlation with pulmonary function tests. Radiology 2002;222:261–270.PubMedGoogle Scholar
  104. 104.
    Fromm GB, Dunn LJ, Harris JO. Desquamative interstitial pneumonitis. Characterization of free intraalveolar cells. Chest 1980;77:552–554.PubMedGoogle Scholar
  105. 105.
    Hartman TE, Primack SL, Kang EY, et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. Chest 1996;110:378–382.PubMedGoogle Scholar
  106. 106.
    Akira M, Yamamoto S, Hara H, Sakatani M, Ueda E. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997;52:333–337.PubMedGoogle Scholar
  107. 107.
    Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004;45:275–282.PubMedGoogle Scholar
  108. 108.
    Hartman TE, Primack SL, Swensen SJ, Hansell D, McGuinness G, Muller NL. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993;187:787–790.PubMedGoogle Scholar
  109. 109.
    Kubo M, Koshino T, Shimizu H, et al. A case of desquamative interstitial pneumonia with increased numbers of eosinophils in the bronchoalveolar lavage fluid. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:1084–1092.PubMedGoogle Scholar
  110. 110.
    Matsuo K, Tada S, Kataoka M et al. Spontaneous remission of desquamative interstitial pneumonia. Intern Med 1997;36:728–731.PubMedGoogle Scholar
  111. 111.
    Kitaichi M. Desquamative interstitial pneumonia: an idiopathic interstitial pneumonia with a possibility of spontaneous regression. Intern Med 1997;36:672–673.PubMedGoogle Scholar
  112. 112.
    Stillwell P, Norris DG, O’Connell EJ, Rosenow EC, Weiland LH, Harrison EG. Desquamative interstitial pneumonitis in children. Chest 1980;77:165–171.PubMedGoogle Scholar
  113. 113.
    Tal A, Maor E, Bar-Ziv J, Gorodischer R. Fatal desquamative interstitial pneumonia in three infants siblings. J Pediatr 1984;104:873–876.PubMedGoogle Scholar
  114. 114.
    Herbert A, Sterling G, Abraham J, Corrin B. Desquamative interstitial pneumonia in an aluminum welder. Hum Pathol 1982;13:694–699.PubMedGoogle Scholar
  115. 115.
    Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985;147:107–119.PubMedGoogle Scholar
  116. 116.
    Freed JA, Miller A, Gordon RE, Fischbein A, Kleinerman J, Langer AM. Desquamative interstitial pneumonia associated with chrysotile asbestos fibres. Br J Ind Med 1991;48:332–337.PubMedGoogle Scholar
  117. 117.
    Hamadeh MA, Atkinson J, Smith LJ. Sulfasalazine-induced pulmonary disease. Chest 1992;101:1033–1037.PubMedGoogle Scholar
  118. 118.
    Amir G, Ron N. Pulmonary pathology in Gaucher’s disease. Hum Pathol 1999;30:666–670.PubMedGoogle Scholar
  119. 119.
    Aubry MC, Wright JL, Myers JL. The pathology of smoking-related lung diseases. Clin Chest Med 2000;21:11–35, vii.PubMedGoogle Scholar
  120. 120.
    Nagai S, Hoshino Y, Hayashi M, Ito I. Smoking-related interstitial lung diseases. Curr Opin Pulmon Med 2000;6:41519.Google Scholar
  121. 121.
    Ryu JH, Colby TV, Hartman TE, Vassallo R. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001;17:122–132.PubMedGoogle Scholar
  122. 122.
    Selman M. The spectrum of smoking-related interstitial lung disorders: the never-ending story of smoke and disease. Chest 2003;124:1185–1187.PubMedGoogle Scholar
  123. 123.
    Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003;124:1199–1205.PubMedGoogle Scholar
  124. 124.
    Rice AJ, Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am J Clin Pathol 2003;119:709–714.PubMedGoogle Scholar
  125. 125.
    Olson J, Colby TV, Elliott CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990;65:1538–1548.PubMedGoogle Scholar
  126. 126.
    Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993;103:1808–1812.PubMedGoogle Scholar
  127. 127.
    Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 1997;168:79–83.Google Scholar
  128. 128.
    Kitaichi M. Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto University 1990;23:1–18.Google Scholar
  129. 129.
    Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 2003;22:821–826.PubMedGoogle Scholar
  130. 130.
    Vourlekis JS, Brown KK, Cool CD et al. Acute interstitial pneumonitis—case series and review of the literature. Medicine 2000;79:369–378.PubMedGoogle Scholar
  131. 131.
    Ichikado K, Suga M, Muller NL, et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 2002;165:1551–1556.PubMedGoogle Scholar
  132. 132.
    Suga T, Sugiyama Y, Ohno S, Kitamura S. Two cases of IIP which developed acute exacerbation after bronchoalveolar lavage. Nihon Kyobu Shikkan Gakkai Zasshi 1994;32:174–178.PubMedGoogle Scholar
  133. 133.
    Enomoto T, Kawamoto M, Kunugi S, et al. Clinicopathological analysis of patients with idiopathic pulmonary fibrosis which became acutely exacerbated after video-assisted thoracoscopic surgical lung biopsy. Nihon Kokyuki Gakkai Zasshi 2002;40:806–811.PubMedGoogle Scholar
  134. 134.
    Colby TV. Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992;102:38S–43S.PubMedGoogle Scholar
  135. 135.
    Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993;14:611–622.PubMedGoogle Scholar
  136. 136.
    Davison AG, Heard BE, McCallister WAC, Turner-Warwick MEH. Cryptogenic organising pneumonitis. Q J Med 1983;52:383–394.Google Scholar
  137. 137.
    King TEJ, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest 1992;102:8S–13S.PubMedGoogle Scholar
  138. 138.
    Cordier JF. Organising pneumonia. Thorax 2000;55:318–328.PubMedGoogle Scholar
  139. 139.
    Kramer MR, Saldana MJ, Ramos M, Pitchenik AE. High titres of Epstein-Barr virus antibodies in adult patients with lymphocytic interstitial pneumonitis associated with AIDS. Respir Med 1992;86:49–52.PubMedGoogle Scholar
  140. 140.
    Barbera JA, Hayashi S, Hegele RG, Hogg JC. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridisation. Am Rev Respir Dis 1992;145:940–946.PubMedGoogle Scholar
  141. 141.
    Kaan PM, Hegele RG, Hayashi S, Hogg JC. Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia. Thorax 1997;52:12–16.PubMedGoogle Scholar
  142. 142.
    Andiman WA, Eastman R, Martin K, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985;2:1390–1393.PubMedGoogle Scholar
  143. 143.
    Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA. Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology 1987;19:178–185.PubMedGoogle Scholar
  144. 144.
    Strimlan CV, Rosenow EC, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 1978;88:616–621.PubMedGoogle Scholar
  145. 145.
    Nicholson AG, Wotherspoon AC, Diss TC, et al. Reactive pulmonary lymphoid disorders. Histopathology 1995;26:405–412.PubMedGoogle Scholar
  146. 146.
    Yousem SA, Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod Pathol 2002;15:1148–1153.PubMedGoogle Scholar
  147. 147.
    Churg A, Myers J, Suarez T, et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol 2004;28:62–68.PubMedGoogle Scholar
  148. 148.
    Fukouka J, Franks TJ, Colby TV, et al. Peribronchiolar metaplasia (PBM): a common incidental histologic lesion and a rare cause of interstitial lung disease (PBM-ILD). Mod Pathol 2004;17:336A.Google Scholar
  149. 149.
    Fan LL, Langston C. Chronic interstitial lung disease in children. Pediatr Pulmonol 1993;16:184–196.PubMedGoogle Scholar
  150. 150.
    Bokulic RE, Hilman BC. Interstitial lung disease in children. Pediatr Clin North Am 1994;41(3):543–567.PubMedGoogle Scholar
  151. 151.
    Katzenstein A-LA, Gordon LP, Oliphant M, Swender PT. Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 1995;19(4):439–447.PubMedGoogle Scholar
  152. 152.
    Schroeder SA, Shannon DC, Mark EJ. Cellular interstitial pneumonitis in infants: a clinicopathologic study. Chest 1992;101:1065–1069.PubMedGoogle Scholar
  153. 153.
    Bush A, du Bois RM. Congenital and pediatric interstitial disease. Curr Opin Pulmonol Med 1996;2:347–356.Google Scholar
  154. 154.
    Bush A. Diagnosis of interstitial lung disease. Pediatr Pulmonol 1996;22:81–82.PubMedGoogle Scholar
  155. 155.
    Fan LL. Evaluation and therapy of chronic interstitial pneumonitis in children. Curr Opin Pediatr 1994;6:248–254.PubMedGoogle Scholar
  156. 156.
    Clement A, Allen J, Corrin B, et al. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004;24:686–697.PubMedGoogle Scholar
  157. 157.
    Nicholson AG, Kim H, Corrin B, et al. The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology 1998;33:203–211.PubMedGoogle Scholar
  158. 158.
    Katzenstein A-L, Askin FB. Pediatric disorders. In: Katzenstein M, Askin FB, eds. Surgical pathology of nonneoplastic lung disease. Philadelphia: WB Saunders, 1997:361–382.Google Scholar
  159. 159.
    Fan LL. Pediatric interstitial lung disease. In: Schwartz MI, King TE Jr, eds. Interstitial lung disease. Hamilton: Decker, 1998:103–188.Google Scholar
  160. 160.
    Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344(8):573–579.PubMedGoogle Scholar
  161. 161.
    Nogee LM. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu Rev Physiol 2004;66:601–623.PubMedGoogle Scholar
  162. 162.
    Waters KA, Bale P, Isaacs D, Mellis C. Successful chloroquine therapy in a child with lymphoid interstitial pneumonitis. J Pediatr 1991;119:989–991.PubMedGoogle Scholar
  163. 163.
    Sharief N, Crawford OF, Dinwiddie R. Fibrosing alveolitis and desquamative interstitial pneumonitis. Pediatr Pulmonol 1994;17:359–365.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Andrew G. Nicholson
    • 1
  1. 1.Department of HistopathologyNational Heart and Lung Institute Division of Imperial College School of Medicine and Consultant Histopathologist, Royal Brompton HospitalLondonUK

Personalised recommendations